PTT評價 maomaoder 過去發表過的文章
5
Re: [請益] TDOC和LVGOAs set forth in the definitive joint proxy statement and prospectus, each share of Livongo will be exchanged for 0.5920 shares of Teladoc Health plus cash consideration of $4.24. Additionally, prior to the closing of the merger, Livongo will pay a cash dividend of $7.09 per share of Livongo common stock to stockholders of Livongo as of a record date immediately prior to closing of the merger. 合併後每1股LVGO 可以換得0.592股TDOC츴.24的現金對價 並由LVGO 付7.09的現金股息11
[標的] TLSA 拉回多1. 標的:NASDAQ: TLSA (目前6.99) Tiziana Life Sciences PLC 這不是特斯拉! 這不是特斯拉! 這不是特斯拉!2
[標的] KTOS 多1. 標的:NASDAQ: KTOS (目前19.4) 2. 分類:多,目標22~25 3. 分析/正文: —Seeking Alpha: Kratos Defense & Security (NASDAQ:KTOS) announces that Kratos Unmanned Systems Division has been awarded a five-year contract valued at up to $400M from the U.S. Airforce.5
[心得] FAAMG v.s S&P 其餘495:FAAMG本益比太高啦! :遲早會落下神壇,你看股災也跌呀! ——— FAAMG在2020年增長15%;其餘495支標普股票下跌8%8
Fw: [新聞] 英國科學家疫苗研發有顯著突破作者: maomaoder (毛毛的) 看板: ForeignEX 標題: [新聞] 英國科學家疫苗研發有顯著突破 時間: Wed Feb 5 19:02:16 2020 1.媒體來源: Sky News 2.記者署名: Ashish Joshi